Designing proteins and their functions using computational methods
Equipment Supplement - Computational design of proteins and protein functions
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11037688
This study is exploring how to design new proteins that can help with different medical treatments, which could lead to better therapies for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11037688 on ClinicalTrials.gov |
What this research studies
This research focuses on the computational design of proteins, which are essential molecules that perform a variety of functions in the body. By utilizing advanced computational techniques, the project aims to create new proteins with specific functions that could be beneficial in various medical applications. Patients may benefit from this research as it could lead to the development of novel therapies or treatments based on engineered proteins. The approach involves a combination of genetic engineering and computational modeling to predict how proteins will behave and interact.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated or improved through protein-based therapies.
Not a fit: Patients with conditions unrelated to protein function or those who do not respond to protein-based treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative protein-based therapies that improve treatment options for various diseases.
How similar studies have performed: Other research in protein engineering has shown promising results, indicating that this approach has the potential for significant advancements in medical treatments.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KORTEMME, TANJA — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: KORTEMME, TANJA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.